Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Wenhui Lou MD"'
Publikováno v:
Cancer Control, Vol 27 (2020)
Pancreatic cancer with synchronous liver metastasis has an extremely poor prognosis, and surgery is not recommended for such patients by the current guidelines. However, an increasing body of studies have shown that concurrent resection of pancreatic
Externí odkaz:
https://doaj.org/article/8c8a4851402c497cba765139602da007
Autor:
Wentao Zhou MD, Xu Han MD, Yuan Fang MD, Siyang Han MD, Yumeng Cai MD, Tiantao Kuang MD, Wenhui Lou MD, Dansong Wang MD
Publikováno v:
Cancer Control, Vol 27 (2020)
Backgrounds: Acinar cell carcinoma of the pancreas is a rare malignancy, and its features remain unclear. We aimed to analyze the clinical characteristics, treatment and prognosis of acinar cell carcinoma with our institutional case series. Methods:
Externí odkaz:
https://doaj.org/article/c4c2470f43124098bf8e137b751dfb57
Autor:
Wenming Wu, MD, Gang Jin, MD, Haimin Li, MD, Yi Miao, MD, Chunyou Wang, MD, Tingbo Liang, MD, Jinrui Ou, MD, Yongfu Zhao, MD, Chunhui Yuan, MD, Yixiong Li, MD, Wenhui Lou, MD, Zheng Wu, MD, Renyi Qin, MD, Huaizhi Wang, MD, Jihui Hao, MD, Xianjun Yu, MD, Heguang Huang, MD, Guang Tan, MD, Xubao Liu, MD, Kesen Xu, MD, Lei Wang, MD, Yinmo Yang, MD, Chunyi Hao, MD, Weilin Wang, MD, Kejian Guo, MD, Junmin Wei, MD, Yifan Wang, MD, Chenghong Peng, MD, Xuefeng Wang, MD, Shouwang Cai, MD, Jianxin Jiang, MD, Xinmin Wu, MD, Xiao Yu, MD, Fei Li, MD, Yupei Zhao, MD, Pancreatic Surgery Study Group of Chinese Society of Surgery of Chinese Medical Association
Publikováno v:
Journal of Pancreatology, Vol 2, Iss 2, Pp 35-42 (2019)
Objective: The aim of this study is to investigate the current status of the diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms (pNENs) undergoing surgery in China. Methods: This is a multicenter cross-sectional study perfor
Autor:
Wenming Wu, MD, Gang Jin, MD, Chunyou Wang, MD, Yi Miao, MD, Huaizhi Wang, MD, Wenhui Lou, MD, Xianjun Yu, MD, Bei Sun, MD, Haimin Li, MD, Renyi Qin, MD, Zheng Wu, MD, Weilin Wang, MD, Kesen Xu, MD, Lei Wang, MD, Tingbo Liang, MD, Chunyi Hao, MD, Heguang Huang, MD, Yixiong Li, MD, Guang Tan, MD, Yongfu Zhao, MD, Jihui Hao, MD, Yifan Wang, MD, Chenghong Peng, MD, Xubao Liu, MD, Jinrui Ou, MD, Chunhui Yuan, MD, Xuefeng Wang, MD, Yinmo Yang, MD, Shouwang Cai, MD, Kejian Guo, MD, Jianxin Jiang, MD, Xiao Yu, MD, Junmin Wei, MD, Fei Li, MD, Xinmin Wu, MD, Yupei Zhao, MD, and Pancreatic Surgery Study Group of Chinese Society of Surgery of Chinese Medical Association
Publikováno v:
Journal of Pancreatology, Vol 2, Iss 1, Pp 16-21 (2019)
Objective: The aim of this study is to investigate the current status of pancreatic cancer patients undoing surgical treatment in China and to find ways to improve the survival of these patients in the future. Methods: This study is a national, multi
Autor:
Taiping Zhang, MD, Zhe Cao, MD, Rufu Chen, MD, Yiqi Du, MD, Defei Hong, MD, Kuirong Jiang, MD, Gang Jin, MD, Fei Li, MD, Weiqin Li, MD, Zhaoshen Li, MD, Tingbo Liang, MD, Quan Liao, MD, Wenhui Lou, MD, Yi Miao, MD, Jiaming Qian, MD, Renyi Qin, MD, Bei Sun, MD, Zhaohui Tang, MD, Chunyou Wang, MD, Weilin Wang, MD, Wenming Wu, MD, Yinmo Yang, MD, Gang Zhao, MD, Yupei Zhao, MD, Study Group of Pancreatic Surgery in Chinese Society of Surgery of Chinese Medical Association, Pancreatic Disease Committee of Chinese Research Hospital Association
Publikováno v:
Journal of Pancreatology, Vol 1, Iss 1, Pp 30-34 (2018)
A consensus statement on the diagnosis and treatment of pancreatic exocrine insufficiency (PEI) after pancreatic surgery was developed based on the latest references, combined with China’s actual situation. More than 20 Chinese excellent experts pa
Autor:
Xi Guo, MD, Yaolin Xu, MD, Yuan Ji, MD, Yue Fan, MD, Dansong Wang, MD, Dayong Jin, MD, Rongyuan Zhuang, MD, Lili Wu, MD, Wenhui Lou, MD, Yuhong Zhou, MD
Publikováno v:
Journal of Pancreatology, Vol 3, Iss 1, Pp 35-41 (2020)
Abstract. To compare efficacy and safety of nab-paclitaxel plus gemcitabine (AG) with nab-paclitaxel plus S-1 (AS) as first-line treatment for metastatic pancreatic cancer, we conducted a retrospective analysis by reviewing medical records of 53 meta
Externí odkaz:
https://doaj.org/article/603bd054a3f549eaa85092af73c73f56
Publikováno v:
Journal of Pancreatology, Vol 2, Iss 1, Pp 6-10 (2019)
Abstract. Pancreatic ductal adenocarcinoma is the known kind of tumor biologically featured as high malignant degree, lack of effective methods for diagnosis and treatment, which reflects its unpleasant prognosis. Recently, with the breakthrough of b
Externí odkaz:
https://doaj.org/article/805210008be64f0594d9d9d5016ba7f4
Autor:
Lin Cong, MD, Wenming Wu, MD, Wenhui Lou, MD, Jinwan Wang, MD, Feng Gu, MD, Jiaming Qian, MD, Jianming Xu, MD, Feng Bi, MD, Sanjun Cai, MD, Chengwei Tang, MD, Yulong He, MD, Jie Zhong, MD, Yupei Zhao, MD
Publikováno v:
Journal of Pancreatology, Vol 1, Iss 1, Pp 35-38 (2018)
Abstract. Objectives:. The aim of this multicenter, prospective, registry study was to summarize the epidemiology of Chinese patients with locally advanced and end-stage gastroenteropancreatic neuroendocrine tumors (GEP-NETs) as well as the diagnosti
Externí odkaz:
https://doaj.org/article/cec9d66413ea4fff9c853600745a8e31